Keyphrases
ChimeraX
50%
Chimeric Vaccine
100%
Clinical Testing
25%
Development Testing
25%
Further Development
25%
G-phase
25%
Greggs
25%
Healthy Adults
50%
High Risk
25%
Immunogenicity
100%
Older Subjects
100%
Phase II Clinical Trial
25%
Placebo-controlled
25%
Randomized Double-blind
25%
Vaccine Candidate
25%
Watson
25%
West Nile Neuroinvasive Disease
25%
West Nile Virus
100%
West Nile Virus Vaccine
75%
Yellow Fever
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Vaccine
100%
Clinical Trial
25%
Disease
25%
Immunogenicity
100%
Normal Human
50%
Placebo
25%
West Nile Vaccine
75%
West Nile Virus
100%
Yellow Fever
25%
Immunology and Microbiology
Immunogenicity
100%
Normal Human
50%
West Nile Vaccine
75%
West Nile Virus
100%
Yellow Fever
25%